[Immunosuppressive properties of a new cytostatic agent of beta-chloroethylene series, spirazidine].
D000707:Anaphylaxis / Q000188:drug therapy; D000818:Animals; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001249:Asthma / Q000188:drug therapy; D006168:Guinea Pigs; D006801:Humans; D013141:Spiro Compounds / Q000627:therapeutic use*
D000970:Antineoplastic Agents; D013141:Spiro Compounds
Izuchenie immunodepressivnykh svoĭstv novogo tsitostatika beta-khlorétilaminovogo riaa-spirazidina.